KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Shares Issued (2016 - 2025)

Rigel Pharmaceuticals (RIGL) has 16 years of Shares Issued data on record, last reported at $2.9 million in Q4 2025.

  • For Q4 2025, Shares Issued rose 99.86% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $8.1 million, up 312.47%, while the annual FY2025 figure was $8.1 million, 312.47% up from the prior year.
  • Shares Issued reached $2.9 million in Q4 2025 per RIGL's latest filing, down from $4.3 million in the prior quarter.
  • Across five years, Shares Issued topped out at $4.3 million in Q3 2025 and bottomed at $1000.0 in Q1 2023.
  • Average Shares Issued over 5 years is $948052.6, with a median of $553000.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: crashed 99.89% in 2023, then skyrocketed 8800.0% in 2024.
  • A 5-year view of Shares Issued shows it stood at $1.1 million in 2021, then tumbled by 46.08% to $585000.0 in 2022, then decreased by 16.92% to $486000.0 in 2023, then surged by 201.44% to $1.5 million in 2024, then soared by 99.86% to $2.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $2.9 million in Q4 2025, $4.3 million in Q3 2025, and $418000.0 in Q2 2025.